New hope for pancreatic cancer: targeted pill study goes fully remote
Disease control
Recruiting now
This study tests a drug called pemigatinib in 40 adults with advanced or metastatic pancreatic cancer that has certain changes in the FGFR gene. The drug aims to block these abnormal genes and stop tumor growth. The study is done entirely through telemedicine, so participants can…
Phase: PHASE2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated May 15, 2026 11:58 UTC